After Pear: Why Digital Therapeutics Are Ending Up Inside Clinics
Dr. Dereck Mush, MD, MBA
PursueCare
Virtual addiction treatment with multidisciplinary clinical services and prescription digital therapeutics.
PursueCare is known for virtual addiction treatment with multidisciplinary clinical services and prescription digital therapeutics. It sits in our Mental & Behavioural Health category.
What they do
PursueCare provides personalized telehealth addiction treatment and care for co-occurring mental health conditions in Connecticut, Kentucky, Maine, New Hampshire, Ohio and West Virginia. XRHealth announced its acquisition on November 9, 2026, including RESET and RESET-O, FDA-authorized prescription digital therapeutics. Nicholas Mercadante was identified as founder and CEO at the announcement; no post-acquisition title is inferred.
People in this update
- Nicholas MercadanteFounder and CEO at the acquisition announcementSource
The record
- Vertical
- Mental & Behavioural Health
- Sub-segment
- Virtual addiction treatment
- Product type
- Platform software
- Stage
- Headquarters
- Not disclosed
- Region
- Founded
- Not disclosed
- Total funding
- Undisclosed
Also in Mental & Behavioural Health
More in Mental & Behavioural Health: Mental & Behavioural Health startups/HealthTech startup database
Related on The Signal
Dr. Dereck Mush, MD, MBA
School based teletherapy is moving from pilot programme to standard infrastructure
Dr. Dereck Mush, MD, MBA
The MCT8 Treatment Boundary: What Emcitate's Approval Changes and What It Leaves Open
Dr. Dereck Mush, MD, MBA
Medicare finally pays for prescription digital therapeutics, and the test begins
Dr. Dereck Mush, MD, MBA